Dr Carl Fortin
Consulting Editor: Carl Fortin (PhD)
Department of Microbiology, Infectiology and Immunology. Faculty of Medecine, Université de Montréal, Canada
Dr. Fortin recently joined the Institute for Research in Immunology and Cancer (IRIC) as a senior Postdoctoral Fellow in the Department of Microbiology, Infectiology, and Immunology, Faculty of Medicine, at Université de Montréal, Canada. He joined the team of Dr. Étienne Gagnon with the goal of establishing Zinc homeostasis modulation in tumor infiltrating lymphocytes (TILs) as a novel mechanism of tumor-induced tolerance and as a potential target for immunotherapies. He received his MSc in Immunology from the Faculty of Medicine and Health Sciences in 2006 at Université de Sherbrooke, Canada. The topic of his research was to determine the effects of human aging on neutrophils, which are the most potent phagocytic cells of the immune system. Dr. Fortin completed his PhD in Immunology from the Faculty of Medicine and Health Sciences in 2011 at Université de Sherbrooke, Canada. During his PhD, he contributed to characterize the signaling pathways used by human neutrophils to secrete chemokines in response to inflammatory stimuli at the transcriptional and translational levels. He continued with postdoctoral work at the Duke University Medical Center where he investigated the role of natural killers (NK) cells in the innate immune response against live vaccinia virus, a potent vaccine vehicle for treating cancer and infectious diseases. He was the recipient of doctoral and postdoctoral awards from Canadian funding agencies.